High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 1, 2010, Pages 134-136

  Paramesparan, Yasothararan ^a   Garvey, Lucy J ^b   Ashby, Jane ^b   Foster, Caroline J ^b   Fidler, Sarah ^a   Winston, Alan ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ATTENTION; BRAIN TOXICITY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LETTER; LINEAR REGRESSION ANALYSIS; MALE; MEMORY; MIXED INFECTION; MORBIDITY; PATIENT ATTITUDE; PILOT STUDY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; VERTICAL TRANSMISSION; HOSPITALIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PREVALENCE;

ADOLESCENT; AGED; AIDS DEMENTIA COMPLEX; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77956626885     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181d90e8c     Document Type: Letter

References (15)

1. Patel K, Ming X, Williams PL, et al, and International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS. 2009;23:1893-1901.
2. Keller MA, Venkatraman TN, Thomas A, et al. Altered neurometabolite development in HIV-infected childrendcorrelation with neuropsychological tests. Neurology. 2004;62:1810-1817. (Pubitemid 38661740)
3. Brouwers P, De Carli C, Tudor-Williams G, et al. Interrelations among patterns of change in neurocognitive, CT brain imaging and CD4 measures associated with anti-retroviral therapy in children with symptomatic HIV infection. Adv Neuroimmunol. 1994;4:223-231. (Pubitemid 24325867)
4. Foster CJ, Biggs RL, Melvin D, et al. Neurodevelopmental outcomes in children with HIV infection under 3 years of age. Dev Med Child Neurol. 2006;48:677-682. (Pubitemid 44044472)
5. Wood SM, Shah SS, Steenhoff AP, et al. The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. AIDS. 2009;23:1859-1865.
6. Cysique LA, Maruff P, Darby D, et al. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21:185-194. (Pubitemid 43117194)
7. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367-1374. (Pubitemid 41800672)
8. Letendre S, Marquie-Beck J, Capparelli E, et al and, Charter Group. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65:65-70.
9. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789-1799. (Pubitemid 350059308)
10. Brackis-Cott E, Kang E, Dolezal C, et al. The impact of perinatal HIV infection on older school-aged children's and adolescents' receptive language and word recognition skills. AIDS Patient Care STDS. 2009;23:415-421.
11. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAARTera. AIDS. 2007;21:1915-1921. (Pubitemid 47329768)
12. Garvey L, Yerrakalva Y, Winston A. Correlations between Computerised Battery Testing and a Memory Questionnaire for Identification of Neurocognitive Impairment in HIV-1 Infected Subjects on Stable Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2009;25:765-769.
13. Tozzi V, Balestra P, Bellagamba R, et al. Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment Prevalence and Risk Factors. J Acquir Immune Defic Syndr. 2007;45:174-182. (Pubitemid 46869810)
14. Albert SM, Weber C, Todak G. An observed performance test of medication management ability in HIV: relation to neuropsychological status and adherence outcomes. AIDS Behav. 1999;3:121-128. (Pubitemid 29316238)
15. Farinpour R, Miller EN, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol. 2003;25:654-670. (Pubitemid 36808151)